Skip to main content
. 2017 Dec 5;12(12):e0188925. doi: 10.1371/journal.pone.0188925

Fig 1. The frequency of patients with therapeutic non-response according to 6-TGN concentrations.

Fig 1

HHS Vulnerability Disclosure